Wall Street Zen Downgrades Afya (NASDAQ:AFYA) to Hold

Afya (NASDAQ:AFYA) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

A number of other research analysts have also commented on the company. Bank of America restated a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Zacks Research lowered shares of Afya from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 6th. Weiss Ratings cut shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a report on Monday, June 22nd. Six equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $18.00.

Afya Price Performance

AFYA stock opened at $13.84 on Friday. Afya has a twelve month low of $13.00 and a twelve month high of $16.50. The company has a quick ratio of 2.20, a current ratio of 2.20 and a debt-to-equity ratio of 0.39. The company has a market cap of $1.30 billion, a PE ratio of 8.44, a price-to-earnings-growth ratio of 1.46 and a beta of 0.34. The business’s 50-day simple moving average is $14.26 and its 200 day simple moving average is $14.41.

Afya (NASDAQ:AFYA) last posted its quarterly earnings results on Thursday, August 13th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.40 by $0.03. Afya had a return on equity of 17.58% and a net margin of 20.55%.The firm had revenue of $187.80 million during the quarter, compared to analysts’ expectations of $189.62 million. On average, research analysts anticipate that Afya will post 1.84 earnings per share for the current year.

Insider Activity at Afya

In related news, VP Gomiero Mirella Basolli sold 10,000 shares of the business’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $14.80, for a total value of $148,000.00. Following the sale, the vice president owned 34,530 shares of the company’s stock, valued at $511,044. The trade was a 22.46% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Lelio De Souza Junior sold 41,541 shares of the company’s stock in a transaction on Friday, June 26th. The shares were sold at an average price of $15.00, for a total value of $623,115.00. Following the completion of the sale, the vice president owned 36,204 shares in the company, valued at $543,060. This trade represents a 53.43% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 87,745 shares of company stock valued at $1,314,175 in the last 90 days.

Institutional Investors Weigh In On Afya

Several large investors have recently made changes to their positions in AFYA. Daiwa Securities Group Inc. acquired a new stake in shares of Afya during the 4th quarter worth about $43,000. Militia Capital Partners LP acquired a new position in Afya in the second quarter valued at about $71,000. Quantbot Technologies LP bought a new stake in Afya during the second quarter worth about $117,000. Van ECK Associates Corp increased its holdings in shares of Afya by 15.7% during the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after buying an additional 1,377 shares in the last quarter. Finally, State of Wyoming acquired a new stake in shares of Afya during the second quarter worth approximately $164,000. Institutional investors own 88.02% of the company’s stock.

Afya News Summary

Here are the key news stories impacting Afya this week:

• Positive Sentiment: Profitability improved: Afya reported second-quarter revenue of $187.8 million, up 10.95% year over year, while net income rose 22.57% to $38.9 million. Diluted EPS increased to $0.43 from $0.40, and operating cash flow reached $64.3 million. Afya Second-Quarter and First-Half 2026 Financial Results
• Positive Sentiment: EPS exceeded the broader consensus: The company’s $0.43 quarterly EPS surpassed the reported consensus estimate of $0.40, while Afya maintained a healthy 20.2% net margin and 17.94% return on equity. Afya Earnings Results
• Positive Sentiment: Cost and balance-sheet trends were supportive: Capital spending declined year over year, cash and equivalents totaled $194.4 million, and total liabilities were broadly unchanged. These factors may reinforce the investment case at a valuation of roughly 9 times earnings.
• Neutral Sentiment: Results were mixed depending on the benchmark: Zacks reported adjusted quarterly EPS of $0.45, slightly below its $0.46 consensus estimate, while revenue also lagged some expectations. Afya Q2 Earnings and Revenues
• Negative Sentiment: Fiscal 2026 revenue guidance was below expectations: Afya projected revenue of $750.2 million to $778.7 million, below the $781.6 million consensus estimate. EPS guidance was not provided in the supplied update, increasing uncertainty around the full-year outlook.
• Negative Sentiment: Insider and institutional selling may weigh on sentiment: Recent data showed 19 insider sales and no insider purchases over six months, while more institutional investors reduced positions than added them. Afya Q2 Earnings and Institutional Activity

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.